These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 8383661

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target?
    Kopp U, Roos M, Wecke J, Labischinski H.
    Microb Drug Resist; 1996; 2(1):29-41. PubMed ID: 9158720
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.
    Strandén AM, Ehlert K, Labischinski H, Berger-Bächi B.
    J Bacteriol; 1997 Jan; 179(1):9-16. PubMed ID: 8981974
    [Abstract] [Full Text] [Related]

  • 7. Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation.
    Ehlert K, Schröder W, Labischinski H.
    J Bacteriol; 1997 Dec; 179(23):7573-6. PubMed ID: 9393725
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Living with an imperfect cell wall: compensation of femAB inactivation in Staphylococcus aureus.
    Hübscher J, Jansen A, Kotte O, Schäfer J, Majcherczyk PA, Harris LG, Bierbaum G, Heinemann M, Berger-Bächi B.
    BMC Genomics; 2007 Sep 04; 8():307. PubMed ID: 17784943
    [Abstract] [Full Text] [Related]

  • 10. Identification of three additional femAB-like open reading frames in Staphylococcus aureus.
    Tschierske M, Mori C, Rohrer S, Ehlert K, Shaw KJ, Berger-Bächi B.
    FEMS Microbiol Lett; 1999 Feb 15; 171(2):97-102. PubMed ID: 10077832
    [Abstract] [Full Text] [Related]

  • 11. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization.
    Berger-Bächi B, Barberis-Maino L, Strässle A, Kayser FH.
    Mol Gen Genet; 1989 Oct 15; 219(1-2):263-9. PubMed ID: 2559314
    [Abstract] [Full Text] [Related]

  • 12. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus.
    Berger-Bächi B, Strässle A, Gustafson JE, Kayser FH.
    Antimicrob Agents Chemother; 1992 Jul 15; 36(7):1367-73. PubMed ID: 1510429
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. FmhA and FmhC of Staphylococcus aureus incorporate serine residues into peptidoglycan cross-bridges.
    Willing S, Dyer E, Schneewind O, Missiakas D.
    J Biol Chem; 2020 Sep 25; 295(39):13664-13676. PubMed ID: 32759309
    [Abstract] [Full Text] [Related]

  • 15. The pentaglycine bridges of Staphylococcus aureus peptidoglycan are essential for cell integrity.
    Monteiro JM, Covas G, Rausch D, Filipe SR, Schneider T, Sahl HG, Pinho MG.
    Sci Rep; 2019 Mar 21; 9(1):5010. PubMed ID: 30899062
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis.
    Koyama N, Tokura Y, Münch D, Sahl HG, Schneider T, Shibagaki Y, Ikeda H, Tomoda H.
    PLoS One; 2012 Mar 21; 7(11):e48981. PubMed ID: 23166602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.